focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 135.00
Ask: 145.00
Change: 2.00 (1.45%)
Spread: 10.00 (7.407%)
Open: 131.00
High: 140.00
Low: 131.00
Prev. Close: 138.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

10 Jul 2012 08:09

RNS Number : 2592H
Revolymer PLC
10 July 2012
 



10 July 2012

Revolymer plc

("Revolymer" or "the Group")

Julian Heslop to Join the Board of Revolymer

 

Former CFO of GSK to become an Independent Non-Executive Director

 

Revolymer, the British polymer company developing products for a number of high value fast moving consumer goods ("FMCG") markets, is pleased to announce that, as a consequence of the Group's admission to the AIM Market today, the appointment of Julian Heslop to the Board has now become effective.

 

Julian served as Chief Financial Officer of GlaxoSmithKline plc ("GSK") between April 2005 and March 2011. He was also Chairman of ViiV Healthcare Limited until March 2011. He served as Senior Vice President, Operations Controller of GSK between January 2001 and March 2005 and as Financial Controller of Glaxo Wellcome plc from April 1998 to December 2000. Prior to this, Julian had senior finance roles at Grand Metropolitan plc and Imperial Brewing and Leisure. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

Julian Heslop, commenting on his appointment said, "I am delighted to be joining the Board of Revolymer. I look forward to playing an active role as the Group seeks to generate significant value from its broad product pipeline by signing a number of licensing deals with important players in the FMCG markets it is targeting."

 

Jack Keenan, Chairman of Revolymer commenting on today's announcement said, "Julian's decision to join the Board of Revolymer, upon its Admission to AIM, is an important endorsement of the Group's technology and the market opportunities that it has chosen to pursue. His financial knowledge and experience in both pharmaceutical and FMCG markets will be extremely valuable as the company seeks to develop its business."

 

Further information on Julian Spenser Heslop as required by AIM Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies is to be found in paragraph 4 of Part VI of the Group's Admission Document which was published on 4 July 2012 and available at www.revolymer.com

 

 

Ends

 

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

 

Panmure Gordon (UK) Limited

+44 (0) 20 7459 3600

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

 

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Ginny Pulbrook / David Dible

 

About Revolymer

 

Revolymer® is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the confectionery chewing gum and medicated chewing gum (together "gum") markets; and in coatings & adhesives, household products and personal care (together "consumer specialties").

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOARLMATMBAMBTT
Date   Source Headline
6th Aug 20194:50 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSPDMR Shareholding
2nd Aug 20192:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20192:00 pmRNSPrice Monitoring Extension
2nd Aug 201911:05 amRNSSecond Price Monitoring Extn
2nd Aug 201911:00 amRNSPrice Monitoring Extension
29th Jul 20196:03 pmRNSBlock listing Interim Review
19th Jul 20193:28 pmRNSResult of AGM
17th Jul 20197:00 amRNSHalf-Year Trading Update
10th Jul 20194:41 pmRNSSecond Price Monitoring Extn
10th Jul 20194:35 pmRNSPrice Monitoring Extension
9th Jul 20195:19 pmRNSHolding(s) in Company
27th Jun 20197:00 amRNSPreliminary Results
14th Jun 20197:00 amRNSNotice of Results
29th May 20197:00 amRNSSale of Minority Interest in Alkalon
21st May 20197:00 amRNSFirst personal care purchase order from Nouryon
20th May 20197:00 amRNSBoard Change
3rd May 20197:00 amRNSFirst European Order for New Detergent Polymer
2nd Apr 20194:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20192:05 pmRNSSecond Price Monitoring Extn
28th Feb 20192:00 pmRNSPrice Monitoring Extension
28th Feb 20199:00 amRNSPersonal care agreement with Nouryon
18th Feb 201911:06 amRNSSecond Price Monitoring Extn
18th Feb 201911:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSFull Year Trading Update
15th Jan 20194:40 pmRNSSecond Price Monitoring Extn
15th Jan 20194:35 pmRNSPrice Monitoring Extension
15th Jan 20199:00 amRNSDetergent polymer agreement with Nouryon
9th Jan 20192:20 pmRNSBlock listing Interim Review
5th Dec 20187:00 amRNSNew Licence Agreement with New Wave
26th Oct 20187:00 amRNSDirectorate Change
2nd Oct 20187:00 amRNSBoard Changes
27th Sep 20187:00 amRNSInterim results
9th Aug 20181:41 pmRNSResult of AGM
6th Aug 20187:00 amRNSAppointment of Interim Chief Financial Officer
3rd Aug 20188:51 amRNSDirector/PDMR Dealings
3rd Aug 20188:47 amRNSBoard Changes
2nd Aug 201812:49 pmRNSExercise of Options, Directors' Dealing & TVR
2nd Aug 201811:57 amRNSResult of General Meeting
1st Aug 201810:02 amRNSResult of Open Offer & US Additional Subscription
16th Jul 20187:30 amRNSRestoration - Itaconix plc
13th Jul 20183:58 pmRNSReplacement re Further Details on the Fundraising
13th Jul 20183:54 pmRNSBlock listing Interim Review
13th Jul 20183:26 pmRNSRestoration of Trading
13th Jul 201812:11 pmRNSPosting of Circular & Annual Report & Notice of GM
12th Jul 20184:47 pmRNSFurther Details on the Fundraising
12th Jul 20187:05 amRNSProposed Fundraising
12th Jul 20187:00 amRNSPreliminary Results
29th Jun 20187:30 amRNSSuspension - Itaconix Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.